Chondrocytes cultured in vitro retain their capacity to synthesize and secrete proteoglycans. In vivo as well as in vitro most of the proteoglycans participate in the extracellular formation of large aggregates together with hyaluronic acid and link protein (Hascall & Heinegard, 1974a,b; Kimura et al., 1979 Kimura et al., , 1980 Bj6rnsson & Heinegird, 198 lb) . A substantial proportion of the proteoglycans is, however, associated with the cell surface, even in single-cell suspension cultures (Bj6rnsson & Heinegard, 198 la). The relative size of this cell-associated pool varies with the culture system used, and the mechanism for the binding of proteoglycans to the chondrocyte cell surface is not known. The turnover of these proteoglycans is slow (Mikuni-Takagaki & Toole, 1979; Bj6rnsson & Heinegird, 198 la) , making it unlikely that the pool of proteoglycans at the cell surface only represents an intermediate step in the export into the medium.
Binding of proteoglycans to cells has been studied with other cell types. In the case of heparan sulphate proteoglycans bound to the surface of hepatocytes, the interaction is mediated by two different mechanisms. One fraction binds via the polysaccharide side chains to a cell-surface receptor, and another is bound via a hydrophobic region in the proteoglycan core protein, which is believed to be integral in the membrane (Kjellen et al., 1980, 198 1) . Other studies have shown that fibroblast proteoglycans can bind to fibroblasts, probably via their protein core (Prinz et al., 1978) . These proteoglycans were internalized, however, and therefore represent a degradation pool rather than a structural one. In the present investigation we have studied the ability of chondrocytes in suspension culture to bind exogenous cartilage proteoglycans. Such Articular-cartilage proteoglycans were prepared from metacarpophalangeal joints of 6-month-old calves. These proteoglycans were extracted with 4 M-guanidinium chloride/5 mM-N-ethylmaleimide/ 50mM-sodium acetate buffer, pH 5.8, containing the protein inhibitors 5 mM-benzamidinium chloride, 0.1 M-6-aminohexanoic acid and 10mM-EDTA. Solid CsCl was added to the extract to increase the density to 1.50g/ml. The proteoglycans were isolated by equilibrium centrifugation in an MSE 6 x 14 ml swinging-bucket rotor at 30000 rev./min (10000g8) for 65h at 18°C. The bottom quarter of the tube was separated with a Beckman tube slicer. This fraction had a density of 1.61g/ml and contained the bulk of the proteoglycans. Nasalseptum-cartilage proteoglycan aggregates, hyaluronic acid-binding region and a mixture of chondroitin sulphate-attachment region and keratan sulphate-attachment region were prepared as described previously (Heinegard & Axelsson, 1977) . Human umbilical-cord hyaluronic acid was from Sigma Chemical Co. Hyaluronic acid oligomers were prepared by the method of Hascall & Heinegard (1974b) .
Isolation ofcells
Articular-cartilage chondrocytes were prepared from metacarpophalangeal joints from forelegs of 6-month-old calves. Hyaline cartilage was dissected from all articular-cartilage surfaces of the joint and cut into small pieces. The cell-suspension procedure was essentially the one described by Bjornsson & Heinegird (1981a) for the preparation of foetal-calf tracheal chondrocytes. In short, the chondrocytes were liberated by collagenase digestion (0.2%, w/v) under constant agitation for 9h at 37°C. The cells were washed and transferred to spinner bottles containing Ham's F12 medium with supplements. The cells were kept in spinner culture at 37°C for 2 days to allow them to reconstitute their cell surface.
Preparation of ["Slsulphate-labelledproteoglycans Chondrocytes (0.5 x 106 cells/ml) were cultured in Ham's F 12 medium containing 20 mM-Hepes, pH 7.5, and 50i.u. of penicillin/ml on hydrophobic bacteriological Petri dishes. Carrier-free [35S]sulphate (The Radiochemical Centre, Amersham, Bucks., U.K.) (20,uCi/ml) was added. After 6 days the medium was collected and concentrated by ultrafiltration (PM 10; Amicon, Lexington, MA, U.S.A.). An equal volume of 8 M-guanidinium chloride was added to the concentrated medium, followed by solid CsCl to give a density of 1.50 g/ml. The 35S-labelled proteoglycans were recovered from the bottom quarter of the tubes after equilibrium centrifugation, as described above.
Proteoglycan preparations were dialysed against water, freeze-dried and dissolved in medium to make a concentrated stock solution for use in binding experiments.
Binding experiments
Cells were collected from spinner culture by centrifugation, washed twice with Ham's F 12 medium, and suspended in fresh medium (containing no dextran sulphate) at a concentration of 2 x 106 cells/ml essentially as described previously (Bj6rnsson & Heinegard, 198 1b) . Samples (1 ml) of the cell suspension were pipetted into 2 ml polypropylene vials that had been precoated with bovine serum albumin (1 mg/ml in distilled water for 15 h at 200C) to minimize non-specific binding to the walls. The cells were incubated for 1.5-2 h on a gyrating board (Nutator; Becton and Dickinson Labware, Oxnard, CA, U.S.A.) before the start of the experiment.
Addition of labelled proteoglycans was done either by pipetting 10,l of a concentrated stock solution directly into the cell suspension or by suspending cells that had been pelleted (30s in an Eppendorf model 3200 centrifuge operated at 90 V) in 1 ml of fresh medium containing labelled proteoglycans. The amounts of proteoglycan bound were similar in the different procedures. When desired, competitors for binding were also added to the medium containing labelled proteoglycans. After incubation at 370C on the gyrating board, the cells were pelleted by centrifugation and the medium was removed for determination of radioactivity. The cells were washed once by resuspending them in fresh medium followed by centrifugation, and this rinse was discarded. The efficiency of the rinsing procedure would allow less than 0.05% of non-bound proteoglycans to be recovered with the cell pellet. This pellet was finally suspended in 1ml of Dulbecco's phosphate-buffered saline, pH 7.3 (Flow Laboratories), and samples were taken for determination of radioactivity. Before liquid-scintillation counting, samples of media and cells were made 1% (w/v) with respect to sodium dodecyl sulphate, heated at 600C for 30min and mixed with scintillation 'cocktail' (Instagel; Packard, Downers Grove, IL, U.S.A.) in a ratio of 1: 10.
Results and discussion

Characterization of [35S[sulphate-labelled proteoglycans
Preparations of 3"S-labelled proteoglycans were characterized by gel chromatography on Sepharose 2B. The major proportion of the proteoglycans was eluted as high-M, monomers (Heinegfird, 1972) (Fig.   la ). The ability of these labelled monomers to form aggregates with hyaluronic acid was demonstrated by the shift of a large proportion to the void volume after incubation with hyaluronic acid (2%, w/w) (Fig. lb) . The presence of the keratan sulphateattachment region, typical for cartilage proteoglycans (Heinegard & Axelsson, 1977) (Fig. 2) . The amount of 35S-labelled proteoglycans that was bound to the chondrocytes increased rapidly during the first 2 h of incubation. The rate at which additional proteoglycans bound then decreased, and maximum binding was slowly reached within 5 h.
Vol. 214 Cells were pelleted by centrifugation and resuspended in 1lml of medium containing "5S-labelled proteoglycans (o, l,ug/ml, *, 5,ug/ml). The amount of '5S-labelled proteoglycans associated with cells was determined after incubation as described in the Experimental section.
Localization of bound [35S]sulphate-labelledproteoglycans
To determine to what extent the bound proteoglycans were cell-surface-associated, the cells were allowed to bind 35S-labelled proteoglycans for 2-5 h and were then treated briefly with trypsin (for details see Fig. 3 legend) . At all times more than 86% of bound 3"S label was released by the digestion (Fig.  3) , indicating a cell-surface localization of bound 35S-labelled proteoglycans. Only a minor proportion was resistant to trypsin digestion and was recovered with the cell fraction, possibly representing internalized proteoglycans. This supports earlier studies on endocytosis of proteoglycans by chicken chondrocytes (von Figura et al., 1980) . These cells bound cartilage proteoglycans, which, however, were not internalized.
Concentration-dependence of binding of [35S]sulphate-labelledproteoglycans
To investigate if the capacity of the chondrocytes to bind proteoglycans is saturable, various amounts of 35S-labelled proteoglycans were added to 2 x 106 cells in 1 ml of medium and incubated for 2 h. There was no sharp transition in amount bound when increasing amounts of 35S-labelled proteoglycans were added (Fig. 4a) decrease in the proportion bound at concentrations above 16,ug/ml (Fig. 4b ). It appears that the saturation of the binding is not absolute, but that, when a certain number of proteoglycans are bound, additional molecules bind with less affinity, and possibly by other mechanisms. If the binding of proteoglycans to the cell surface is part of the construction of an extracellular matrix, no sharp division between cell-surface proteoglycans and extracellular matrix should be expected. In agreement, electron microscopy of articular-cartilage cells in monolayer culture shows a diffuse layer containing proteoglycans and collagen at the cell surface of the chondrocytes, indicating establishment of an extracellular matrix (Kuettner et al., 1982 (Fig. 5) . Both articular-cartilage and nasal-septum-cartilage (results not shown) proteoglycan monomers efficiently inhibited binding of the 3"S-labelled proteoglycans (Fig. 5a ). About 50,ug of articular-cartilage monomer is needed to give 50% inhibition of binding when 4,ug of 35S-labelled proteoglycans is present. One possible explanation for this is that these two preparations contain different proportions of two or more types of proteoglycans that differ in their cell-binding properties. Nasal-septum-cartilage proteoglycan aggregate preparation (A 1) containing mainly link-proteinstabilized aggregates was a less efficient competitor (Fig. 5b) . Compared with proteoglycan monomers, about 7 times more (by wt.) of the proteoglycan aggregate preparation was needed to achieve 50% inhibition of binding of 3"S-labelled proteoglycans.
Nasal-septum-cartilage A1 preparations have been shown to contain about 15% proteoglycan monomers (Heinegard & Hascall, 1979) , since a substantial portion of these monomers can interact with hyaluronic acid in vitro, it appears that the inhibition obtained with this preparation could be due solely to the presence of free monomer. Addition of reduced and alkylated articular-cartilage proteoglycan monomer (64,ug/ml) decreased the binding of 3"S-labelled proteoglycans to 75% of the control value, whereas intact monomers at this concentration decreased binding to 40% (Fig. 5a ). Because reduction of monomers will only modify the hyaluronic acid-binding region (Heinegard, 1977) , it appeared that this structure may be involved in the binding to cells.
Various substructures of proteoglycan monomer were used in the competition assay to identify the part of the molecule that binds to the cell surface.
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Isolated hyaluronic acid-binding region competed efficiently with the 3"S-labelled proteoglycans for binding (Fig. 5c ). On the other hand, a preparation containing a mixture of chondroitin sulphate-attachment region and keratan sulphate-attachment region (Al:T:A1; Heinegard & Axelsson, 1977) did not compete for binding (Fig. Sd) . A somewhat increased binding of 35S-labelled proteoglycans in the presence of chondroitin sulphate-attachment region and keratan sulphate-attachment region seems to be a general effect of anionic polymers, since dextran sulphate gave a similar, but even more pronounced, effect (Fig. 5g) .
The hyaluronic acid-binding region was the only efficient competitor among the proteoglycan substructures, suggesting that the 35S-labelled proteoglycans bind to the cell by this part of the molecule. Furthermore, when 35S-labelled proteoglycans were reduced and alkylated to unfold the hyaluronic acid-binding region, binding was decreased to 2% compared with that of untreated proteoglycans (results not shown). Assuming, then, that proteoglycans bind to chondrocytes by their hyaluronic acid-binding region, a probable receptor structure is hyaluronic acid at the cell surface. If so, hyaluronic acid should be an efficient competitor, as was indeed the case (Fig. 5e ). Further support for this mechanism for attachment was obtained by determining the size of hyaluronic acid required for efficient competition. The decasaccharide was the smallest hyaluronic acid oligosaccharide to compete efficiently (Fig. Sf) , exactly as has been previously described for binding of proteoglycan monomer to hyaluronic acid in the formation of cartilage proteoglycan aggregates (Hardingham & Muir, 1973; Hascall & Heinegard, 1974b ).
Release of cell-bound [35Slsulphate-labelled proteoglycans by treatment with Streptomyces hyaluronidase The role of hyaluronic acid at the cell surface in the binding of 3"S-labelled proteoglycans was further studied by specific enzymic degradation. Digestion of chondrocytes with Streptomyces hyaluronidase released more than 95% of 3"S-labelled proteoglycans that had been bound to the cells (Table 1) . To inhibit the proteolytic activity known to be present in the hyaluronidase preparation (Caputo et al., 1980) , ovomucoid plus newborn-calf serum, known to contain several proteinase inhibitors, was included in digestion buffers. Under such conditions the 35S-labelled proteoglycan was not degraded during digestion, as judged by Sepharose 2B chromatography (results not shown). Furthermore, the aggregating capacity of the 35S-labelled proteoglycans remained. No proteolytic activity was (Ohya & Kaneko, 1970 detected in the mixture of hyaluronidase and proteinase inhibitors, with [3H]acetyl-labelled haemoglobin as the substrate. The detection limit of this assay is low, corresponding to 0.1 ng of trypsin/ml. A 100-fold higher amount of trypsin (lOng) than the highest possible proteinase activity of the digestion mixture containing 1 turbidityreducing unit of hyaluronidase did not release any 3"S label from the cells ( Table 1) . The almost complete removal of bound 3"S-labelled proteoglycans by digestion with Streptomyces hyaluronidase demonstrates that the 3"S-labelled proteoglycans are indeed bound to hyaluronic acid at the cell surface.
Reversibility of binding of [35S]sulphate-labelled proteoglycans to chondrocytes
The binding of proteoglycans to hyaluronic acid in proteoglycan aggregates is stabilized by link protein (Heinegard & Hascall, 1974; Kimura et al., 1979; Hardingham, 1979) . Such link-protein-stabilized aggregates are stable to competition with hyaluronic acid or proteoglycan monomers. Proteoglycans at the cell surface of chondrocytes have a slow turnover (Mikuni-Takagaki & Toole, 1979; Bj6rnsson & Heinegird, 1981b) . It is therefore possible that proteoglycan binding to hyaluronic acid at the chondrocyte cell surface is stabilized, possibly by link proteins. If so, they should not be readily displaced by either exogenous or newly synthesized proteoglycans. To investigate this possibility, 35S-labelled proteoglycans were allowed to bind to the cells for 1 h and 4 h. Attempts were then made to displace bound proteoglycans by the addition of fresh medium containing the same competitors as used before (Fig. 6) . In control cultures, bound 35S-labelled proteoglycans decreased to 75% of the initial value during 3 h, i.e. 25% of bound proteoglycans were released. Competitors added to the cells at a concentration that would effectively compete for the initial binding resulted in release of only 39% of the 35S-labelled proteoglycans. There was no significant difference between the results when 35S-labelled proteoglycans were allowed to bind for 1 h or 4 h, other than the total amount bound. Thus binding of 35S-labelled proteoglycans is not a freely reversible process. It is likely that the binding is stabilized by an additional factor, possibly link proteins.
General discussion
The present study has shown that cartilage proteoglycans bind via their hyaluronic acid-binding region to hyaluronic acid at the chondrocyte cell surface and that the binding is stable towards competition. It is possible that this hyaluronic acid-proteoglycan complex is stabilized by link proteins, in analogy to the proteoglycan aggregates formed in the medium of chondrocyte cultures and present in cartilage matrix. Internalization is not a major process. Therefore, during the time period studied, the added 31S-labelled proteoglycans seem to be integrated as a part of the pericellular matrix. The proteoglycan molecules in this matrix appeared to be bound to the cells by specific bonds, since reduced and alkylated 3"S-labelled proteoglycans showed no binding.
The different binding of proteoglycans isolated from cultured chondrocytes and isolated from cartilage is puzzling in view of the fact that both preparations have equal capacity to bind to hyaluronic acid in vitro. It may be that the preparations contain different proportions of the two subpopulations of aggregating proteoglycans (Heinegird et al., 1981) , or that proteoglycans are modified with time in the extracellular matrix, such that their hyaluronic acid-binding regions bind less strongly, either to hyaluronic acid or to stabilizing factors.
In cartilage chondrocytes are embedded in an extensive extracellular matrix, containing predominantly collagen and proteoglycans. The chondrocytes seem to be able to regulate the content of macromolecules in this matrix (Hardingham et al., 1972) , by an unknown mechanism. It is possible that feedback control by an interaction between proteoglycans in the matrix and a cell-surface receptor for proteoglycans play a role (Nevo & Dorfman, 1972; Wiebkin & Muir, 1977; Lowther & Handley, 1979) . Other potential regulating factors are hormonal influences, mechanical properties of the matrix, and interactions with collagen and other matrix components. Suspension cultures are well suited for identification of specific cell-surface receptors for proteoglycans, as the cells do not accumulate an extracellular matrix as in monolayer cultures. The approach used does not exclude additional mechanisms for proteoglycan association with the chondrocyte. There may be a pool of proteoglycans bound to the cell surface by a different mechanism.
